LIFECORE BIOMEDICAL, INC. (LFCR) Return on equity 2016–2025
LIFECORE BIOMEDICAL, INC. (LFCR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2896.7%FY2025 · since FY2016: -5.5% → -2896.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2896.7% | -3002.8 pp |
| FY2024 | 106.1% | — |
| FY2022 | -132.9% | -116.9 pp |
| FY2021 | -16.0% | +0.6 pp |
| FY2020 | -16.6% | -16.8 pp |
| FY2019 | 0.2% | -9.7 pp |
| FY2018 | 9.8% | +5.2 pp |
| FY2017 | 4.7% | +10.2 pp |
| FY2016 | -5.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice